By Dr Mark William Donoghoe

Journal articles

Hetherington K; Hunter JD; Donoghoe MW; McGillycuddy M; McGill BC; Robertson EG; Tyrrell V; Lau LMS; Marron JM; Tucker KM; Marshall GM; Vetsch J; Haber M; Malkin D; Mateos MK; O’Brien TA; Ziegler DS; Wakefield CE, 2026, 'Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancer', npj Genomic Medicine, http://dx.doi.org/10.1038/s41525-026-00591-y

Hetherington K; Hunter J; Donoghoe M; McGillycuddy M; McGill B; Robertson E; Tyrrell V; Lau L; Marron J; Tucker K; Marshall G; Vetsch J; Haber M; Malkin D; Mateos M; Brien TO; Ziegler D; Wakefield C, 2026, 'ID #107 Family experiences of precision-guided treatment recommendations for poor prognosis paediatric Central Nervous System (CNS) cancer', Neuro-Oncology Pediatrics, 2, pp. wuag026.020, http://dx.doi.org/10.1093/neuped/wuag026.020

Rhodes M; Signorelli C; Donoghoe MW; McLoone JK; Wakefield CE; Anazodo A; Sansom-Daly UM; Darlington AS; Sodergren SC; Cohn RJ; Fardell JE, 2026, 'Factors associated with health-related quality of life in survivors of childhood-onset and adult-onset cancer compared to controls', Supportive Care in Cancer, 34, http://dx.doi.org/10.1007/s00520-026-10775-y

Januszewski AS; Huang MLH; Mangani AS; Ong KL; Dalton C; O'Connell RL; Li L; Sullivan DR; Strbenac D; Donoghoe MW; Brown C; Carroll LM; Gebski V; Scott RS; John Simes R; Jenkins AJ; Keech AC, 2026, 'Chronic complication risk and benefits of fenofibrate in type 2 diabetes by a PPARα polymorphism (rs6008845, C/T): a FIELD trial substudy', Diabetes Research and Clinical Practice, 234, pp. 113168 - 113168, http://dx.doi.org/10.1016/j.diabres.2026.113168

Nyein PP; Donoghoe MW; Eriobu N; Uche B; Kaplan R; Carey D; Brown D; Kundro M; Dharan NJ; Hanson J; Petoumenos K; Matthews GV, 2026, 'Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trial', AIDS, Publish Ahead of Print, http://dx.doi.org/10.1097/QAD.0000000000004476

Sansom-Daly UM; Irestorm E; Houweling R; Hetherington K; McGill BC; Ellis SJ; Schilstra CE; Donoghoe MW; Bravery BD; Cohn RJ; Anazodo A; Wakefield CE, 2026, 'Do young people who have been treated for cancer identify as ‘survivors’? Adolescents and young adults’ preferences for cancer-related identities in survivorship', Journal of Cancer Survivorship, http://dx.doi.org/10.1007/s11764-026-02074-6

Donoghoe MW; Sazzad HMS; Han WM; Bloch M; Baker DA; Eu B; Bowden-Reid E; Smith DE; Hoy JF; Woolley IJ; Finlayson R; Templeton DJ; Matthews GV; Costello J; Dawson MA; Dawson SJ; Polizzotto MN; Agbosu E; Kelleher AD; Petoumenos K; Phetsouphanh C; Yeh P; Dharan NJ; Donoghoe MW; Han WM; Bloch M; Vincent T; Baker DA; Eu B; Lau H; Smith DE; Acklom K; Hoy JF; Price S; Woolley I; O’Bryan J; Finlayson R; Templeton DJ; Sinclair B; Matthews G; Costello J; Dawson MA; Dawson SJ; Polizzotto MN; Kelleher AD; Petoumenos K; Yeh P; Dharan NJ, 2026, 'Gut health is associated with clonal haematopoiesis in older adults with and without HIV: the ARCHIVE longitudinal cohort study', Gut, pp. gutjnl-2025-337620, http://dx.doi.org/10.1136/gutjnl-2025-337620

Acheson LS; Siefried KJ; Lintzeris N; Dunlop AJ; Haber PS; Arunogiri S; Christmass M; Doyle M; Donoghoe M; Nagle J; Clifford B; McKetin R; Lubman DI; Brett J; Taylor N; Carr A; Levin FR; Shoptaw S; Ezard N, 2025, 'Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settings', BMJ Open, 15, pp. e107242 - e107242, http://dx.doi.org/10.1136/bmjopen-2025-107242

Signorelli C; McLoone J; Wakefield C; Donoghoe M; Alchin JE; Johnston K; Baldwin R; Thornton-Benko E; Webber K; Foreman T; Neville K; Cohn R, 2025, 'Engage: A Survivorship Program to Improve Childhood Cancer Survivors' Self-Efficacy and Quality of Life', JCO Oncology Practice, 21, pp. 1274 - 1286, http://dx.doi.org/10.1200/OP-24-00815

Ha L; Wakefield CE; Jacovou J; Johnston K; Drew D; Donoghoe MW; Mizrahi D; Lourenco RDA; Cohn RJ; Taylor N; Signorelli C; Roughley K; Joyner C; Wright A, 2025, '‘Making Moves’: Protocol for a hybrid effectiveness-implementation pre-post trial of a co-designed online physical activity program for childhood cancer survivors', Jsams Plus, 5, http://dx.doi.org/10.1016/j.jsampl.2025.100099

Schilstra CE; Wakefield CE; McLoone J; Wiener L; Donoghoe MW; Hoffman RI; Echodu M; Ortiz R; Ilbawi A; Cayrol J, 2025, 'Development of a World Health Organization international survey assessing the lived experience of people affected by cancer: outcomes from pilot testing, user feedback, and survey revision', Supportive Care in Cancer, 33, http://dx.doi.org/10.1007/s00520-025-09372-2

Foster C; Donoghoe M; Battisti A; D'Eugenio F; Harborne K; Venville T; Lagos C; Mendel JT; Bagge R; Barsanti S; Bellstedt S; Boecker A; Chen Q; Derkenne C; Ferré-Matteu A; Gjergo E; Gupta A; Muller E; Santucci G; Park HJ; Remus RS; Thater S; Van De Sande J; Vaughan SP; Brough S; Croom S; Valenzuela L; Wisnioski E, 2025, 'The MAGPI Survey: The kinematic morphology-density relation (or lack thereof) and the Hubble sequence at z ∼ 0.3', Publications of the Astronomical Society of Australia, 42, http://dx.doi.org/10.1017/pasa.2025.19

Ezard N; Clifford B; Siefried KJ; Ali R; Dunlop A; McKetin R; Bruno R; Carr A; Ward J; Farrell M; Graham R; Haber P; Lubman D; Donoghoe MW; Olsen N; Baker A; Hall M; Arunogiri S; Lintzeris N; Gill A; Rodgers C; Montebello M; Liaw W; Liu Z, 2025, 'Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial', Addiction, 120, pp. 1345 - 1359, http://dx.doi.org/10.1111/add.16730

Robertson EG; Hetherington K; Daly R; Donoghoe MW; Handelsman N; Ziegler DS; Wakefield CE, 2024, 'The feasibility and acceptability of collecting psychosocial outcome measures embedded within a precision medicine trial for childhood cancer', Cancer Medicine, 13, http://dx.doi.org/10.1002/cam4.7339

Cayrol J; Wakefield CE; Ilbawi A; Donoghoe M; Hoffman R; Echodu M; Schilstra C; Ortiz R; Wiener L, 2024, 'The lived experience of people affected by cancer: A global cross-sectional survey protocol', Plos One, 19, pp. e0294492, http://dx.doi.org/10.1371/journal.pone.0294492

Donoghoe MW; Marschner IC, 2024, 'Parameter expansion for fitting regression models with non-negativity constraints', Communications in Statistics Simulation and Computation, 53, pp. 4412 - 4429, http://dx.doi.org/10.1080/03610918.2022.2154791

Hetherington K; Wakefield CE; McGill BC; Tucker KM; Donoghoe MW; Daly R; Hunter JD; Ballinger M; Fuentes-Bolanos NA; Ziegler DS, 2024, 'When genetics and pediatric cancer collide: Understanding and optimizing families' experiences', Neuro Oncology Advances, 6, http://dx.doi.org/10.1093/noajnl/vdae133

Gereis JM; Hetherington K; Robertson EG; Daly R; Donoghoe MW; Ziegler DS; Marshall GM; Lau LMS; Marron JM; Wakefield CE, 2023, 'Parents’ and adolescents’ perspectives and understanding of information about childhood cancer precision medicine', Cancer, 129, pp. 3645 - 3655, http://dx.doi.org/10.1002/cncr.34914

McGill BC; Wakefield CE; Tucker KM; Daly RA; Donoghoe MW; Vetsch J; Warby M; Fuentes-Bolanos NA; Barlow-Stewart K; Kirk J; Courtney E; O’Brien TA; Marshall GM; Pinese M; Cowley MJ; Tyrrell V; Deyell RJ; Ziegler DS; Hetherington K, 2023, 'Parents’ expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial', Cancer, 129, pp. 3620 - 3632, http://dx.doi.org/10.1002/cncr.34917

Wakefield CE; Hetherington K; Robertson EG; Donoghoe MW; Hunter JD; Vetsch J; Marron JM; Tucker KM; Marshall GM; Broom A; Haber M; Tyrrell V; Malkin D; Lau L; Mateos MK; O’Brien TA; Ziegler DS, 2023, 'Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives', British Journal of Cancer, 129, pp. 1634 - 1644, http://dx.doi.org/10.1038/s41416-023-02429-1

Craig AT; Leong RNF; Donoghoe MW; Muscatello D; Mojica VJC; Octavo CJM, 2023, 'Comparison of statistical methods for the early detection of disease outbreaks in small population settings', IJID Regions, 8, pp. 157 - 163, http://dx.doi.org/10.1016/j.ijregi.2023.08.007

Spitzer H; Berry S; Donoghoe M; Pelkmans L; Theis FJ, 2023, 'Learning consistent subcellular landmarks to quantify changes in multiplexed protein maps', Nature Methods, 20, pp. 1058 - 1069, http://dx.doi.org/10.1038/s41592-023-01894-z

Shamsa A; Gilchrist RB; Robertson DM; Rodgers RJ; Donoghoe MW; Ledger WL; Abbott JA; Riepsamen AH, 2023, 'Oocyte-Secreted Serum Biomarkers GDF9 and BMP15 in Women with Endometriosis', Reproductive Sciences, 30, pp. 1521 - 1527, http://dx.doi.org/10.1007/s43032-022-01107-6

Riepsamen AH; Donoghoe MW; Indran IR; Hechtman L; Robertson DM; Gilchrist RB; Ledger WL; Yong EL, 2023, 'Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome', Clinical Endocrinology, 98, pp. 567 - 577, http://dx.doi.org/10.1111/cen.14851

Ong KL; O'Connell RL; Januszewski AS; Donoghoe MW; Gebski V; Sullivan D; Rye KA; Scott RS; Best JD; Taskinen M-R; Simes RJ; Jenkins A; Keech AC, 2023, 'Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study', DIABETES, 72, http://dx.doi.org/10.2337/db23-1350-P

Body A; Donoghoe MW; Ahern ES; Lal L; Downie P; Leahy MF; Fuentes-Bolanos N; Anazodo A; Padhye B; Hamad N; Wakefield CE; Segelov E, 2023, 'Safety and patient reported outcomes of SARS-CoV-2 vaccination in patients with cancer', ANNALS OF ONCOLOGY, 34, pp. S1104 - S1104, http://dx.doi.org/10.1016/j.annonc.2023.09.888

Schilstra CE; McCleary K; Fardell JE; Donoghoe MW; McCormack E; Kotecha RS; Lourenco RDA; Ramachandran S; Cockcroft R; Conyers R; Cross S; Dalla-Pozza L; Downie P; Revesz T; Osborn M; Alvaro F; Wakefield CE; Marshall GM; Mateos MK; Trahair TN, 2022, 'Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia', BMC Cancer, 22, pp. 985, http://dx.doi.org/10.1186/s12885-022-10072-x

Hetherington K; Wakefield CE; Kunalan KPK; Donoghoe MW; McGill BC; Fardell JE; Daly R; Deyell RJ; Ziegler DS, 2022, 'Quality of Life (QoL) of Children and Adolescents Participating in a Precision Medicine Trial for High-Risk Childhood Cancer', Cancers, 14, http://dx.doi.org/10.3390/cancers14215310

RIEPSAMEN AH; DONOGHOE MW; INDRAN IR; LIEN S; HECHTMAN L; ROBERTSON DM; GILCHRIST RB; YONG E-L; LEDGER WL, 2022, 'Serum GDF9 and BMP15 as Markers of Ovarian Function in Healthy Women and Women with Polycystic Ovary Syndrome', Fertility & Reproduction, 04, pp. 141 - 141, http://dx.doi.org/10.1142/s266131822274053x

Kamaladasa DS; Sansom-Daly UM; Hetherington K; McGill BC; Ellis SJ; Kelada L; Donoghoe MW; Evans H; Anazodo A; Patterson P; Cohn RJ; Wakefield CE, 2021, 'How Are Families Faring? Perceived Family Functioning among Adolescent and Young Adult Cancer Survivors in Comparison to Their Peers', Journal of Adolescent and Young Adult Oncology, 10, pp. 711 - 719, http://dx.doi.org/10.1089/jayao.2020.0215

Sansom‐daly UM; Wakefield CE; Signorelli C; Donoghoe MW; Anazodo A; Sawyer SM; Osborn M; Viney R; Daniell N; Faasse K; Cohn RJ; Sansom-Daly U, 2021, 'Patterns and predictors of healthcare use among adolescent and young adult cancer survivors versus a community comparison group', Cancers, 13, pp. 5270, http://dx.doi.org/10.3390/cancers13215270

Wakefield CE; Sansom‐daly UM; McGill BC; Hetherington K; Ellis SJ; Robertson EG; Donoghoe MW; McCarthy M; Kelada L; Girgis A; King M; Grootenhuis M; Anazodo A; Patterson P; Lowe C; Dalla‐pozza L; Miles G; Cohn RJ; Sansom-Daly U, 2021, 'Providing psychological support to parents of childhood cancer survivors: ‘cascade’ intervention trial results and lessons for the future', Cancers, 13, pp. 5597, http://dx.doi.org/10.3390/cancers13225597

Riepsamen AH; Donoghoe MW; Baerwald A; Pankhurst MW; Lien S; Chong YH; Robertson DM; Ledger WL; Gilchrist RB, 2021, 'Exploratory analysis of serum concentrations of oocyte biomarkers growth differentiation factor 9 and bone morphogenetic protein 15 in ovulatory women across the menstrual cycle', Fertility and Sterility, 116, pp. 546 - 557, http://dx.doi.org/10.1016/j.fertnstert.2021.02.001

Riepsamen AH; Donoghoe MW; Baerwald A; Pankhurst MW; Lien S; Chong YH; Robertson DM; Ledger WL; Gilchrist RB, 2021, 'Serum Concentrations of GDF9 and BMP15 Across the Menstrual Cycle', Journal of the Endocrine Society, 5, pp. A734 - A735, http://dx.doi.org/10.1210/jendso/bvab048.1494

Sansom‐daly UM; Wakefield CE; Ellis SJ; McGill BC; Donoghoe MW; Butow P; Bryant RA; Sawyer SM; Patterson P; Anazodo A; Plaster M; Thompson K; Holland L; Osborn M; Maguire F; O’dwyer C; Lourenco RDA; Cohn RJ; Sansom-Daly U, 2021, 'Online, group‐based psychological support for adolescent and young adult cancer survivors: Results from the recapture life randomized trial', Cancers, 13, pp. 2460, http://dx.doi.org/10.3390/cancers13102460

Hsu J; Sansom-Daly UM; Hetherington K; Ellis SJ; Donoghoe MW; Cohn RJ; Zentella-Tusie A; Wakefield CE, 2021, 'Health service and medication use of parents of childhood cancer survivors: a controlled comparison study', Acta Oncologica, 60, pp. 1325 - 1334, http://dx.doi.org/10.1080/0284186X.2021.1955968

Barbour AP; Samra JS; Haghighi KS; Donoghoe MW; Burge M; Harris MT; Chua YJ; Mitchell J; O’rourke N; Chan H; Gebski VJ; Gananadha S; Croagh DG; Kench JG; Goldstein D, 2020, 'The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer', Annals of Surgical Oncology, 27, pp. 2506 - 2515, http://dx.doi.org/10.1245/s10434-020-08205-2

Barlow EL; Lambie N; Donoghoe MW; Naing Z; Hacker NF, 2020, 'The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva', Journal of Oncology, 2020, http://dx.doi.org/10.1155/2020/3739075

Kelada L; Wakefield CE; Heathcote LC; Jaaniste T; Signorelli C; Fardell JE; Donoghoe M; McCarthy MC; Gabriel M; Cohn RJ, 2019, 'Perceived cancer-related pain and fatigue, information needs, and fear of cancer recurrence among adult survivors of childhood cancer', Patient Education and Counseling, 102, pp. 2270 - 2278, http://dx.doi.org/10.1016/j.pec.2019.06.022

Riepsamen AH; Chan K; Lien S; Sweeten P; Donoghoe MW; Walker G; Fraison EHJ; Stocker WA; Walton KL; Harrison CA; Ledger WL; Robertson DM; Gilchrist RB, 2019, 'Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 during IVF and in Women with Reproductive Pathologies', Endocrinology, 160, pp. 2298 - 2313, http://dx.doi.org/10.1210/en.2019-00264

Robertson EG; Wakefield CE; Cohn RJ; Battisti RA; Donoghoe MW; Ziegler DS; Fardell JE; Mitchell R; O'Brien TA, 2019, 'Piloting a parent and patient decision aid to support clinical trial decision making in childhood cancer', Psycho Oncology, 28, pp. 1520 - 1529, http://dx.doi.org/10.1002/pon.5109

Stenson BJ; Donoghoe M; Brocklehurst P; Davis PG; Juszczak E; Marschner IC; Simes J; Tarnow-Mordi WO, 2019, 'Pulse Oximeter Saturation Targeting and Oximeter Changes in the Benefits of Oxygen Saturation Targeting (BOOST)-II Australia and BOOST-II UK Oxygen Trials', Journal of Pediatrics, 204, pp. 301 - 304.e2, http://dx.doi.org/10.1016/j.jpeds.2018.08.033

Craig AT; Joshua CA; Sio AR; Donoghoe M; Betz-Stablein B; Bainivalu N; Dalipanda T; Kaldor J; Rosewell AE; Schierhout G, 2018, 'Epidemic surveillance in a low resource setting: Lessons from an evaluation of the Solomon Islands syndromic surveillance system, 2017', BMC Public Health, 18, pp. 1395, http://dx.doi.org/10.1186/s12889-018-6295-7

Donoghoe MW; Marschner IC, 2018, 'Logbin: An R package for relative risk regression using the log-binomial model', Journal of Statistical Software, 86, http://dx.doi.org/10.18637/jss.v086.i09

Mitchell P; Siva S; Kok PS; O'Byrne K; Yeung A; Livingstone A; Donoghoe M; Yip S; Stockler MR, 2017, 'NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.', Journal of Clinical Oncology, 35, pp. TPS9097 - TPS9097, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps9097

Donoghoe MW; Gebski V, 2017, 'The importance of censoring in competing risks analysis of the subdistribution hazard', BMC Medical Research Methodology, 17, pp. 52, http://dx.doi.org/10.1186/s12874-017-0327-3

Nowak A; Kok P-S; Livingstone A; Lesterhuis WJ; Yip S; Donoghoe M; Lam W-S; Stockler M, 2017, 'P2.06-025 DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In', Journal of Thoracic Oncology, 12, pp. S1086 - S1087, http://dx.doi.org/10.1016/j.jtho.2016.11.1518

Donoghoe MW; Marschner IC, 2016, 'Estimation of adjusted rate differences using additive negative binomial regression', Statistics in Medicine, 35, pp. 3166 - 3178, http://dx.doi.org/10.1002/sim.6960

Barbour A; O'Rourke N; Chan H; Chua YJ; Kench J; Hicks RJ; Samra JS; Pavlakis N; Haghighi KS; Yip S; Donoghoe M; Friend C; Burge ME; Fawcett J; Harris M; Aghmesheh M; Joubert WL; Gebski V; Simes J; Goldstein D, 2016, 'Initial survival outcomes for the AGITG GAP study – a phase II study of perioperative nab -paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC).', Journal of Clinical Oncology, 34, pp. 4105 - 4105, http://dx.doi.org/10.1200/jco.2016.34.15_suppl.4105

Williams KH; Sullivan DR; Nicholson GC; George J; Jenkins AJ; Januszewski AS; Gebski VJ; Manning P; Tan YM; Donoghoe MW; Ehnholm C; Young S; O'Brien R; Buizen L; Twigg SM; Keech AC, 2016, 'Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study', Metabolism Clinical and Experimental, 65, pp. 783 - 793, http://dx.doi.org/10.1016/j.metabol.2015.12.008

Back to profile page